Pradžia › Didelis depresinis sutrikimas › Arizona
Didelis depresinis sutrikimas klinikiniai tyrimai Arizona
13 tyrimai dėl Didelis depresinis sutrikimas ieško dalyvių vietose Arizona.
Miestai Arizona
Oficialus tyrimo tekstas (anglų kalba)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- NoesisPharma, LLC, Phoenix
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07775300Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- University of Arizona, Tucson
Renkami dalyviai3 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- IMA Clinical Research- Phoenix, Phoenix
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07621237A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Lighthouse Psychiatry, Gilbert
Renkami dalyviai3 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Phoenix
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06830044Lumateperone for Late-Life Depression
- University of Arizona, Tucson
Renkami dalyviai3 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07623135A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Phoenix
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-02 · NCT07610473A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- IMA Clinical Research Phoenix, Phoenix
Renkami dalyviai3 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-08-03 · NCT06775379A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- NoesisPharma, LLC, Phoenix
- Del Sol Research Management, Tucson
Renkami dalyviai2 fazė
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2026-07-27 · NCT07115329Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Tucson
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-24 · NCT07484217A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Ima Clinical Research Phoenix (Alea) /ID# 277516, Phoenix
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-06-15 · NCT07276997A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Noble Clinical Research, Tucson
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-05-11 · NCT06524830Study of ALTO-300 in MDD
- Site 200, Phoenix
- Site 187, Yuma
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2025-07-24 · NCT05922878Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.